Thrombocytopenic purpura secondary to COVID-19
DOI:
https://doi.org/10.32818/reccmi.a5n2a15Keywords:
purpura, thrombocytopenia, SARS-CoV-2.Abstract
Patient with purpuric lesions and severe platelet disease of 2.0 x 109/L. About respiratory symptoms he only referred dyspnea; on clinical ultrasound, we found B lines in several lung fields suggestive of bilateral pneumonic condensation, confirmed radiographically. SARS-CoV-2 PCR test was positive. The analytical results allowed us to conclude that it was immune thrombocytopenic purpura (ITP) due to that virus.
Treatment with hydroxychloroquine + lopinavir/ritonavir was initiated, also, methylprednisolone and immunoglobulin. The lesions remitted, the dyspnea disappeared and platelets increased. Subsequently, he required treatment with eltrombopag, which normalized platelet count.
Downloads
Metrics
References
W. Guan, Z. Ni, Yu Hu, W. Liang, C. Ou, J, et all. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382: 1708-20. doi: https://doi.org/10.1056/NEJMoa2002032.
Abrar-Ahmad Z, Lorenzo- Villalba N, Hassler P, Andrés E. Immune Thrombocytopenic Purpura in a Patient with Covid-19. N engl j med. doi: https://doi.org/10.1056/NEJMc2010472.
Mo Yang, Margaret HL Ng & Chi Kong Li (2005) Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology, 10:2, 101-105, doi: https://doi.org/10.1080/10245330400026170.
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844–847. doi: https://doi.org/10.1111/jth.14768.
Lillicrap D. Disseminated intravascular coagulation in patients with 2019- nCoV pneumonia. J Thromb Haemost. 2020; 18: 786–787. doi: https://doi.org/10.1111/jth.14781.
Amgalan A, Othman M. Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered questions. Department of Biomedical and Molecular Sciences School of Medicine, Queen's University, Canada. doi: https://doi.org/10.1111/JTH.14832.
Panyang Xu, Qi Zhou, Jiancheno Xu. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol 2020 Apr 15: 1-4. doi: https://doi.org/10.1007/s00277-020-04019-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 María José Macías-Reyes; Olga Ramón-Planell; Cristina Baca-Cano, Marta Cucurell-Palomas, María José Martínez-Gil
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
